Article
HDAC inhibition results in widespread alteration of the histone acetylation landscape and BRD4 targeting to gene bodies
1 Jan 2021
Abstract excerpt
Histone acetylation levels are regulated by histone acetyltransferases (HATs) and histone deacetylases (HDACs) that antagonistically control the overall balance of this post-translational modification. HDAC inhibitors (HDACi) are potent agents that disrupt this balance and are used clinically to treat diseases including cancer. Despite their use, little is known about their effects on chromatin regulators,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
